A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Type 2 Diabetes
Interventions
DRUG

ITCA 650

ITCA 650 is exenatide in DUROS

OTHER

ITCA placebo

Formulation in DUROS (no exenatide)

Trial Locations (121)

10301

Study Site, Staten Island

11218

Study Site, Brooklyn

13760

Study Site, Endwell

15401

Study Site, Uniontown

21204

Study Site, Baltimore

23219

Study Site, Richmond

23510

Study Site, Norfolk

24541

Study Site, Danville

27103

Study Site, Winston-Salem

27401

Study Site, Greensboro

27713

Study Site, Durham

28117

Study Site, Mooresville

28144

Study Site, Salisbury

28209

Study Site, Charlotte

28210

Study Site, Charlotte

28401

Study Site, Wilmington

28557

Study Site, Moorehead City

28602

Study Site, Hickory

29582

Study Site, North Myrtle Beach

29651

Study Site, Greer

30114

Study Site, Canton

30338

Study Site, Atlanta

32081

Study Site, Ponte Vedra

32117

Study Site, Daytona Beach

32205

Study Site, Jacksonville

32216

Study Site, Jacksonville

32258

Study Site, Jacksonville

32806

Study Site, Orlando

33021

Study Site, Hollywood

33026

Study Site, Pembroke Pines

33126

Study Site, Miami

33134

Study Site, Coral Gables

33135

Study Site, Miami

33145

Study Site, Miami

33162

Study Site, North Miami Beach

33175

Study Site, Miami

33183

Study Site, Miami

33432

Study Site, Boca Raton

33603

Study Site, Tampa

33765

Study Site, Clearwater

34208

Study Site, Bradenton

34652

Study Site, New Port Richey

34684

Study Site, Palm Harbor

34747

Study Site, Celebration

35235

Study Site, Birmingham

35801

Study Site, Huntsville

36542

Study Site, Gulf Shores

37920

Study Site, Knoxville

38119

Study Site, Memphis

43213

Study Site, Columbus

43623

Study Site, Toledo

45005

Study Site, Franklin

45236

Study Site, Cincinnati

45242

Study Site, Cincinnati

46123

Study Site, Avon

46131

Study Site, Franklin

46140

Study Site, Greenfield

46383

Study Site, Valparaiso

47304

Study Site, Muncie

47714

Study Site, Evansville

Study Site, Evansville

48197

Study Site, Ypsilanti

48307

Study Site, Rochester

50314

Study Site, Des Moines

57049

Study Site, Dakota Dunes

59101

Study Site, Billings

60607

Study Site, Chicago

60634

Study Site, Chicago

64111

Study Site, Kansas City

67114

Study Site, Newton

68510

Study Site, Lincoln

70006

Study Site, Metaire

Study Site, Metairie

Study Site, Metarie

70119

Study Site, New Orleans

72205

Study Site, Little Rock

73069

Study Site, Norman

73112

Study Site, Oklahoma City

75007

Study Site, Carrolton

75230

Study Site, Dallas

75251

Study Site, Chicago

Study Site, Dallas

76135

Study Site, Fort Worth

76904

Study Site, San Angelo

77057

Study Site, Houston

77083

Study Site, Houston

77095

Study Site, Houston

77375

Study Site, Tomball

77478

Study Site, Sugar Land

78228

Study Site, San Antonio

78229

Study Site, San Antonio

78414

Study Site, Corpus Cristi

78731

Study Site, Austin

78745

Study Site, Austin

80907

Study Site, Colorado Springs

80922

Study Site, Colorado Springs

83404

Study Site, Idaho Falls

83646

Study Site, Meridian

85020

Study Site, Phoenix

85224

Study Site, Chandler

85395

Study Site, Goodyear

89148

Study Site, Las Vegas

90017

Study Site, Los Angeles

90806

Study Site, Long Beach

91607

Study Site, Valley Village

91911

Study Site, Chula Vista

91950

Study Site, National City

92780

Study Site, Tustin

93041

Study Site, Port Hueneme

93721

Study Site, Fresno

94401

Study Site, San Mateo

94545

Intarcia, Hayward

94598

Study Site, Walnut Creek

95076

Study Site, Watsonville

95123

Study Site, San Jose

97701

Study Site, Bend

98057

Study Site, Renton

98336

Study Site, Port Orchard

99202

Study Site, Spokane

02301

Study Site, Brockton

08753

Study Site, Toms River

Sponsors
All Listed Sponsors
lead

Intarcia Therapeutics

INDUSTRY